Karim Malek
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Oncology top 10%
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
- CAR-T cell therapy research
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 4
- HER2/EGFR in Cancer Research 4
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 7
- DNA Repair Mechanisms 2
- Co-authors
- Michael J. Birrer (9 shared papers)Kathleen N. Moore (10 shared papers)Daniel G. Wright (9 shared papers)Ignace Vergote (9 shared papers)David M. O’Malley (7 shared papers)Lainie P. Martin (7 shared papers)Antonio González-Martı́n (4 shared papers)David C. Seldin (7 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Blood (4 papers)Annals of Oncology (3 papers)Cancer Research (2 papers)Leukemia Research (2 papers)
- Partner nations
- United StatesCanadaBelgium
In The Last Decade
Karim Malek
31 papers receiving 754 citations
Peers
Comparison fields: 5 of 65
- Reproductive Medicine 111
- Oncology 279
- Genetics 91
- Aging 16
- Hematology 86
Countries citing papers authored by Karim Malek
This map shows the geographic impact of Karim Malek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karim Malek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karim Malek more than expected).
Fields of papers citing papers by Karim Malek
This network shows the impact of papers produced by Karim Malek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karim Malek. The network helps show where Karim Malek may publish in the future.
Co-authors
The 25 scholars most cited alongside Karim Malek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 117 | |
| 2 | 2004 | 91 | |
| 3 | 2018 | 69 | |
| 4 | 2018 | 65 | |
| 5 | 2018 | 60 | |
| 6 | 2004 | 55 | |
| 7 | 2004 | 36 | |
| 8 | 2005 | 34 | |
| 9 | 2022 | 33 | |
| 10 | 2007 | 32 | |
| 11 | 2004 | 28 | |
| 12 | 2018 | 25 | |
| 13 | 2006 | 24 | |
| 14 | 2011 | 21 | |
| 15 | 2011 | 17 | |
| 16 | 2004 | 14 | |
| 17 | 2022 | 9 | |
| 18 | 2019 | 6 | |
| 19 | 2019 | 5 | |
| 20 | 2021 | 5 |
About Karim Malek
Karim Malek is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Reproductive Medicine and Genetics, having authored 31 papers that have together received 769 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (7 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Advanced Breast Cancer Therapies (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), HER2/EGFR in Cancer Research (4 papers), interferon and immune responses (3 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Reproductive Medicine (111 citations), Oncology (279 citations), Genetics (91 citations), Aging (16 citations) and Hematology (86 citations). Karim Malek has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Michael J. Birrer, Kathleen N. Moore, Daniel G. Wright, Ignace Vergote, David M. O’Malley, Lainie P. Martin, Antonio González-Martı́n, David C. Seldin, Vaishali Sanchorawala and Ursula A. Matulonis. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Oncology, Cancer Research and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.